Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 1/20 | 0.40 |
| ▸ | MMEL1 | Q495T6 | 1/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6810003 | 0.83 | CA1 (0.39) | FOLH1CA1CA2CA9PLA2G2A | |
| SCHEMBL6809999 | 0.78 | SYK (0.41) | PLA2G2A | |
| SCHEMBL6539936 | 0.77 | ANPEP (0.51) | CA1CA2CA9 | |
| SCHEMBL6680807 | 0.77 | AKR1C3 (0.48) | AKR1C3 | |
| SCHEMBL6682568 | 0.76 | AKR1C3 (0.52) | AKR1C3 | |
| SCHEMBL6809995 | 0.75 | CA2 (0.49) | CA1CA2CA9 | |
| SCHEMBL6804596 | 0.74 | CA2 (0.50) | CA1CA2CA9 | |
| Hydrochloric Acid SCHEMBL6800412 | 0.73 | TAAR1 (0.39) | AKR1C2 | |
| Hydrochloric Acid SCHEMBL6800406 | 0.73 | TAAR1 (0.39) | AKR1C2 | |
| SCHEMBL6804598 | 0.73 | LTB4R2 (0.40) | CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FANCD2, FANCI, HRH2 | FOLH1 507/4885AKR1C3 383/4885AKR1C2 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.